Machine learning prediction of anemia events before and after talazoparib dose modification using TALAPRO-2 phase 3 trial data

Data sources

• Data sources (types):
  Clinical trial

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No